#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA3705501	B	Inhibition Assay: For the measurement of β-lactamase inhibitory activity, 100 μM (final concentration) nitrocefin (Oxoid) was used as a substrate, and 2.5% DMSO, 10 μg/mL bovine serum derived albumin (Sigma-Aldrich) and 50 mM phosphate buffer at pH 7.0 were used as a reaction solution. To each well of a 96-well plate were added test compounds (compounds shown in Table 14) and AmpC (final concentration 0.5 nM), followed by pre-incubation at 30° C. for 10 minutes. Nitrocefin was added to each well to be mixed therein, followed by incubation at 30° C. for 20 minutes, and Multiskan Ascent (Thermo Fisher Scientific) was used to measure 492 nm wavelength, thereby measuring nitrocefin hydrolytic activity of AmpC, to determine enzyme inhibitory activity. As a control, a reaction solution excluding AmpC was prepared, and the concentration of a test compound exhibiting 50% inhibition was determined to be IC50 value.	Escherichia coli	2	ALA3638910	single protein format	BindingDB Database
2.	ALA3882466	F	Antibacterial activity against extended-spectrum b-lactamase producing Acinetobacter baumannii NCTC 13301 incubated for 16 to 20 hrs by CLSI method	Acinetobacter baumannii	4	ALA3882388	assay format	Patent Bioactivity Data
3.	ALA3882467	B	Inhibition of beta-lactamase in extended-spectrum b-lactamase producing Acinetobacter baumannii NCTC 13301 assessed as potentiation of cefepime-induced antibacterial activity by measuring cefepime MIC at 4 to 8 ug/ml incubated for 16 to 20 hrs by CLSI method	Acinetobacter baumannii	2	ALA3882388	single protein format	Patent Bioactivity Data
4.	ALA3882468	B	Inhibition of beta-lactamase in extended-spectrum b-lactamase producing Acinetobacter baumannii NCTC 13301 assessed as reduction in bacterial growth coadministered with 4 ug/ml sulbactam incubated for 16 to 20 hrs by CLSI method	Acinetobacter baumannii	1	ALA3882388	single protein format	Patent Bioactivity Data
5.	ALA3882469	F	Antibacterial activity against extended-spectrum b-lactamase producing Acinetobacter baumannii NCTC 13304 incubated for 16 to 20 hrs by CLSI method	Acinetobacter baumannii	4	ALA3882388	assay format	Patent Bioactivity Data
6.	ALA3882470	B	Inhibition of beta-lactamase in extended-spectrum b-lactamase producing Acinetobacter baumannii NCTC 13304 assessed as potentiation of cefepime-induced antibacterial activity by measuring cefepime MIC at 4 to 8 ug/ml incubated for 16 to 20 hrs by CLSI method	Acinetobacter baumannii	2	ALA3882388	single protein format	Patent Bioactivity Data
7.	ALA3882471	B	Inhibition of beta-lactamase in extended-spectrum b-lactamase producing Acinetobacter baumannii NCTC 13304 assessed as reduction in bacterial growth coadministered with 4 ug/ml sulbactam incubated for 16 to 20 hrs by CLSI method	Acinetobacter baumannii	1	ALA3882388	single protein format	Patent Bioactivity Data
8.	ALA3882472	F	Antibacterial activity against extended-spectrum b-lactamase producing Acinetobacter baumannii NCTC 13305 incubated for 16 to 20 hrs by CLSI method	Acinetobacter baumannii	4	ALA3882388	assay format	Patent Bioactivity Data
9.	ALA3882473	B	Inhibition of beta-lactamase in extended-spectrum b-lactamase producing Acinetobacter baumannii NCTC 13305 assessed as potentiation of cefepime-induced antibacterial activity by measuring cefepime MIC at 4 to 8 ug/ml incubated for 16 to 20 hrs by CLSI method	Acinetobacter baumannii	2	ALA3882388	single protein format	Patent Bioactivity Data
10.	ALA3882474	B	Inhibition of beta-lactamase in extended-spectrum b-lactamase producing Acinetobacter baumannii NCTC 13305 assessed as reduction in bacterial growth coadministered with 4 ug/ml sulbactam incubated for 16 to 20 hrs by CLSI method	Acinetobacter baumannii	1	ALA3882388	single protein format	Patent Bioactivity Data
11.	ALA3882475	F	Antibacterial activity against extended-spectrum b-lactamase producing Acinetobacter baumannii S-3 incubated for 16 to 20 hrs by CLSI method	Acinetobacter baumannii	4	ALA3882388	assay format	Patent Bioactivity Data
12.	ALA3882476	B	Inhibition of beta-lactamase in extended-spectrum b-lactamase producing Acinetobacter baumannii S-3 assessed as potentiation of cefepime-induced antibacterial activity by measuring cefepime MIC at 4 to 8 ug/ml incubated for 16 to 20 hrs by CLSI method	Acinetobacter baumannii	2	ALA3882388	single protein format	Patent Bioactivity Data
13.	ALA3882477	B	Inhibition of beta-lactamase in extended-spectrum b-lactamase producing Acinetobacter baumannii S-3 assessed as reduction in bacterial growth coadministered with 4 ug/ml sulbactam incubated for 16 to 20 hrs by CLSI method	Acinetobacter baumannii	1	ALA3882388	single protein format	Patent Bioactivity Data
14.	ALA3882478	F	Antibacterial activity against extended-spectrum b-lactamase producing Acinetobacter baumannii S-4 incubated for 16 to 20 hrs by CLSI method	Acinetobacter baumannii	4	ALA3882388	assay format	Patent Bioactivity Data
15.	ALA3882479	B	Inhibition of beta-lactamase in extended-spectrum b-lactamase producing Acinetobacter baumannii S-4 assessed as potentiation of cefepime-induced antibacterial activity by measuring cefepime MIC at 4 to 8 ug/ml incubated for 16 to 20 hrs by CLSI method	Acinetobacter baumannii	2	ALA3882388	single protein format	Patent Bioactivity Data
16.	ALA3882480	B	Inhibition of beta-lactamase in extended-spectrum b-lactamase producing Acinetobacter baumannii S-4 assessed as reduction in bacterial growth coadministered with 4 ug/ml sulbactam incubated for 16 to 20 hrs by CLSI method	Acinetobacter baumannii	1	ALA3882388	single protein format	Patent Bioactivity Data
17.	ALA3882481	F	Antibacterial activity against extended-spectrum b-lactamase producing Acinetobacter baumannii S-8 incubated for 16 to 20 hrs by CLSI method	Acinetobacter baumannii	4	ALA3882388	assay format	Patent Bioactivity Data
18.	ALA3882482	B	Inhibition of beta-lactamase in extended-spectrum b-lactamase producing Acinetobacter baumannii S-8 assessed as potentiation of cefepime-induced antibacterial activity by measuring cefepime MIC at 4 to 8 ug/ml incubated for 16 to 20 hrs by CLSI method	Acinetobacter baumannii	2	ALA3882388	single protein format	Patent Bioactivity Data
19.	ALA3882483	B	Inhibition of beta-lactamase in extended-spectrum b-lactamase producing Acinetobacter baumannii S-8 assessed as reduction in bacterial growth coadministered with 4 ug/ml sulbactam incubated for 16 to 20 hrs by CLSI method	Acinetobacter baumannii	1	ALA3882388	single protein format	Patent Bioactivity Data
20.	ALA3882484	F	Antibacterial activity against extended-spectrum b-lactamase producing Acinetobacter baumannii S-10 incubated for 16 to 20 hrs by CLSI method	Acinetobacter baumannii	4	ALA3882388	assay format	Patent Bioactivity Data